Carl Financial Statements From 2010 to 2024
| CZMWF Stock | USD 61.22 0.00 0.00% |
Check Carl Zeiss financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Carl Zeiss' main balance sheet or income statement drivers, such as , as well as many indicators such as . Carl financial statements analysis is a perfect complement when working with Carl Zeiss Valuation or Volatility modules.
Carl |
Carl Zeiss Meditec Company Operating Margin Analysis
Carl Zeiss' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Carl Zeiss Operating Margin | 0.21 % |
Most of Carl Zeiss' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carl Zeiss Meditec is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Carl Zeiss Meditec has an Operating Margin of 0.2096%. This is 100.6% lower than that of the Healthcare sector and 104.47% lower than that of the Medical Instruments & Supplies industry. The operating margin for all United States stocks is 103.8% lower than that of the firm.
Carl Zeiss Meditec Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Carl Zeiss's current stock value. Our valuation model uses many indicators to compare Carl Zeiss value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carl Zeiss competition to find correlations between indicators driving Carl Zeiss's intrinsic value. More Info.Carl Zeiss Meditec is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers reporting about 0.60 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Carl Zeiss Meditec is roughly 1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carl Zeiss' earnings, one of the primary drivers of an investment's value.About Carl Zeiss Financial Statements
Carl Zeiss stakeholders use historical fundamental indicators, such as Carl Zeiss' revenue or net income, to determine how well the company is positioned to perform in the future. Although Carl Zeiss investors may analyze each financial statement separately, they are all interrelated. For example, changes in Carl Zeiss' assets and liabilities are reflected in the revenues and expenses on Carl Zeiss' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Carl Zeiss Meditec. Please read more on our technical analysis and fundamental analysis pages.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3531 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Carl Pink Sheet
Carl Zeiss financial ratios help investors to determine whether Carl Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carl with respect to the benefits of owning Carl Zeiss security.